Tango Therapeutics Inc. (TNGX)
NASDAQ · Healthcare
Tango Therapeutics Inc. Net Income 2020–2025
Tango Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Tango Therapeutics Inc. net income for the quarter ending March 31, 2026 was -45.5 M, a 14.14% increase year-over-year.
- Tango Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -108.4 M, a 5.69% decrease year-over-year.
- Tango Therapeutics Inc. annual net income for 2025 was -101.6 M, a 22.03% decrease from 2024.
- Tango Therapeutics Inc. annual net income for 2024 was -130.3 M, a 28.07% increase from 2023.
- Tango Therapeutics Inc. annual net income for 2023 was -101.7 M, a 5.95% decrease from 2022.
- Tango Therapeutics Inc. annual net income for 2022 was -108.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tango Therapeutics Inc. Net Income — FAQ
Tango Therapeutics Inc. (TNGX) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Tango Therapeutics Inc.'s net income?
Tango Therapeutics Inc. (TNGX) reported net income of -$102M for fiscal 2025.
Where can I see TNGX's net income history?
The chart and table above show Tango Therapeutics Inc.'s net income by year and by quarter, including the growth rate.